|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/352 | |
| A61K 36/185 | |||
| A61P 37/00 |
| (11) | Patento numeris | 2182940 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08762489.6 |
| Europos patento paraiškos padavimo data | 2008-06-25 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-05-12 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-03-12 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/GB2008/002183 |
| Data | 2008-06-25 |
| (87) | Numeris | WO 2009/004302 |
| Data | 2009-01-08 |
| (30) | Numeris | Data | Šalis |
| 0713083 | 2007-07-05 | GB |
| (72) |
ROBSON, Philip, GB
GUY, Geoffrey, GB
PERTWEE, Roger, GB
JAMONTT, Joanna, GB
|
| (73) |
GW Pharma Limited,
Porton Down Science Park, Salisbury Wiltshire SP4 0JR,
GB
|
| (54) | USE OF TETRAHYDROCANNABINOL AND/OR CANNABIDIOL FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE |
| USE OF TETRAHYDROCANNABINOL AND/OR CANNABIDIOL FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE |